Can light therapy loosen tight skin? new trial aims to find out

NCT ID NCT04922736

Ongoing Symptom relief Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether 30 sessions of UVA-1 light therapy can improve daily life for people with scleroderma, morphea, or skin hardening from graft-versus-host disease. Thirty adults will report how their symptoms affect everyday tasks before and after treatment. The goal is to see if patient-reported outcomes can capture real-world benefits that standard measures might miss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: UVA-1 phototherapy (light treatment)
What this could lead to: If it works, this could show that UVA-1 therapy meaningfully eases skin tightness and improves daily function for people with sclerosing skin diseases.
What could go wrong: This is a small, early study with only 30 people and no comparison group, so results may not apply widely. The treatment requires many sessions and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic graft versus host disease graft versus host disease localized scleroderma systemic sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GRAFT VS HOST DISEASE MORPHEA SCLERODERMA, SYSTEMIC

Contacts and locations

Locations

University of Utah Dermatology

Murray, Utah, 84132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.